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Objective: To study the effects and trends of the opioid overdose epidemic on deceased 
donor liver transplantation and examine how some regions more effectively utilize their 
population of overdose deaths for recovery of livers for transplant.  
Background: Increases in the rate of overdose deaths have led to a growing portion of the 
deceased organ donor population arising from overdose events1, 2. Many transplant 
centers and recipients decline these livers from overdose donors due to concern for 
disease transmission and the stigma around addiction and drug use 3. The risks of using 
these livers for transplant are continuing to decrease as treatments for diseases such as 
hepatitis C ensure the safety of the recipient despite the donor’s history of drug use, and 
research has indicated that these organs are comparable in quality and recipient survival 
to organs recovered from other donors1,4,5.  
Research Strategies: Use the Pubmed and Google for gathering academic data and 
published papers to determine national and regional trends in recovery and transplant of 
livers from donors who died of overdose. Additional data gathered from Centers for 
Disease Control—CDC—and the Organ Procurement and Transplant Network—OPTN, 
as well as the Scientific Registry of Transplant Recipients—SRTR—report.  
Expectations: This project seeks to determine usage trends in donated livers from donors 
who died by the mechanism of anoxic injury secondary to drug overdose or intoxication 
and compare those data around usage rates regionally to determine what potential 
strategies may work for maximizing the usage of these livers for transplant to help 






The United States is currently facing a shortage of organs for transplant, and many people 
on the transplant waitlist will die prior to being transplanted1. To address this organ 
shortage, it is critical that many people become living donors and that a majority of 
people are registered to be organ donors following their death. In addition, it is crucial 
that when people pass away in situations where deceased organ donation is possible, that 
the organizations and hospitals that coordinate and preform organ recovery and transplant 
recover and transplant as many organs as efficiently as possible. Despite this nationwide 
coordinated effort, there are still areas in which improvements can be made and more 
organs can be recovered and transplanted. One of those areas of major recent growth and 




Over the last several decades, the United States has witnessed a major increase in the 
numbers of opioid and intravenous drug overdose deaths6. This trend has been helped 
along by a host of contributing factors including the increased rates of opioid prescription 
by medical providers, increased marketing of opioids by pharmaceutical companies, 
increased rates of drug use and depression from economic downturns, and, more recently, 
the influx of more synthetic opioids into public consumption such as fentanyl1,6. These 




stemming from respiratory and cardiac arrests. Under these circumstances, they face a 
high likelihood of no meaningful neurological recovery or even brain death. This 
increased likelihood of brain death in otherwise young and healthy people makes them 
ideal candidates for deceased organ donation. The increasing rates of overdose deaths 
have led to anoxic events becoming the largest portion of donor death mechanism, 
passing CVA/stroke and traumatic injury in 2014 (Figure 1)2. Because of this fact, many 
organ procurement organizations (OPOs) and transplant centers have made concerted 
efforts to utilize these organs for transplant, but many are still being needlessly discarded 
or not recovered.  
 
Figure 1.  Cause of death among deceased liver donors nationally 2 
 
The United States Opioid Epidemic 
The United States has seen a marked increase in opioid overdose deaths since the 1990s. 
According to the CDC, from 1999-2019 nearly 500,000 people died from an overdose 




first wave occurred with an increase in opioid prescriptions in the 1990s which was a mix 
of semi-synthetic and natural opioids7. The reaction to this growing trend of prescribed 
opioid overdoses led to a decrease in opioid prescriptions and greater controls on the 
overprescribing of opioid medications. Unfortunately, many people were already struck 
with opioid use disorder when this occurred, and this drove the second wave of the opioid 
epidemic where they began to seek heroin as a replacement for the previously available 
prescription opioids. This second wave started in 2010 with a marked increase in the 
number of heroin deaths8. As the market for heroin increased, illicit drug manufacturers 
saw an opportunity to increase profits with the introduction of illicitly manufactured 
synthetic opioids such as fentanyl. This growth in the availability of synthetic opioids and 
their increased combination with heroin, counterfeit pills, and cocaine led to the third 
wave of the opioid epidemic in 20139. 
 
Concerns Regarding Donors from Overdose Deaths 
One of the major concerns regarding the transplantation of organs from drug overdose 
deaths is the transmission of disease3. Intravenous drug overdose death donors are of 
particular concern due to their heightened exposure to hepatitis B, hepatitis C, and HIV3. 
Due to this concern, it has historically been harder to place these organs for transplant 
even when they have negative pre-recovery serologies3. For some recipients, they may 
see their transplant as the only shot they will have and opt to wait for another organ that 
has a lower risk of disease transmission. While it is true that there is some increased risk 




with those from traumatic death donors based on recipient survival five years post-
transplant1,5.  Young traumatic death donors have historically been viewed as the gold 
standard for organ donation potential1.  
 
Beyond recipient concerns, transplant centers across the country all have varying levels 
of risk they will accept for their recipients. Some will be more aggressive and transplant a 
higher number of transplant candidates with more marginally viable organs while others 
will be more discerning with what organs they accept and which patients they transplant 
to ensure a higher percentage of positive outcomes. This risk can range from quality of 
organ accepted based off of donor past medical history, pre-recovery lab results, as well 
as visualization and biopsy of the organ, and health status of the recipient. However, 
many transplant centers are far more risk averse than their peers and will decline organs 
based off their social history of IV drug use. Regionally, the host OPO which arranged 
organ recovery may change their recovery practices based on their available resources 
and the potential for acceptance based off of previous cases. In addition, some local 
hospitals may be unaware that an overdose patient who has a history of HCV can 
potentially be an organ donor and will not aggressively notify their regional OPO until 
the patient’s family has decided to withdraw care or care has already been withdrawn.  
 
Examples of Positive Developments in Overdose Death Donation 
Of the many areas hit by the opioid epidemic, New England was of particular note as an 




deliberate effort to maximize their recovery of organs from this growing pool of potential 
donors. They focused on aggressive pre-recovery serology testing, comprehensive 
discussion of donor risk with transplant centers, and education of local hospitals on the 
potential for organ donation even in the setting of positive serologies10. This included 
HCV, HBV, and HIV nucleic acid testing or NAT testing for all donors in addition to the 
previous use of antigen and antibody testing10. This additional testing allowed NEDS to 
shrink the window for development of potential unknown donor derived infection from 
several weeks to several days10. This allowed for an increased confidence in the safety of 
transplanting organs even if a donor was a known user of IV opiates. Following these 
changes, the percentage of donors from the NEDS donor service area (DSA) rose from a 
low of 10% in 2013 to 27% in 2016, compared to 7% to 13% over that same timespan 
nationally. Additionally, the development of treatments for HCV and the realization that 
HCV positive organs are viable for transplant allowed NEDS to quadruple the total 
number of HCV positive donors over that same timespan10.  
 
Positive Developments in HCV Positive Donation 
Based on the population of IV opiate users, the major disease of concern is Hepatitis C or 
HCV11. HCV is the leading blood borne illness in the United States and was historically 
the leading disease etiology behind a person being listed for a liver transplant11. The large 
percentage of waitlist recipients with preexisting HCV led to a focus in transplant of first 
utilizing these organs for recipients who were already HCV positive. The discovery and 




many with the disease and allowed for a cure rate of nearly 90%12. In addition, the use of 
these DAA regimens has led to the percentage of patients in the liver transplant waitlist 
declining from 30.6% down to 12.6% over the previous decade2. Following the use of 
these treatments for HCV patients, transplant researchers began looking into the potential 
for transplanting HCV positive donors to HCV negative recipients. The percentage of 
liver transplant candidates developments have led to their being no discernable difference 
in the rate of discard for livers based on donor HCV status (Figure 2)2.  
 
Figure 2. National rate of organ discard for livers from donors by HCV status2 
 
Additionally, the growth in the use of DAAs and their effectiveness has grown the 
percentage of adult recipients willing to accept a liver from an HCV positive donor. It is 
now nearly a fifty-fifty split of recipients willing to accept HCV positive livers and those 
who are not with more recipients being open to receiving an HCV positive liver (Figure 




recipient will be more willing to accept these livers knowing that they can be treated with 
DAAs.  
 
Figure 3. The percentage of adult liver waitlist recipients willing to accept HCV positive livers2 
 
Missed Opportunities 
Despite these major gains in the areas of donation after drug overdose and HCV positive 
organ donation, there are some studies which indicate that there are potential organ 
donors being missed. A 2018 study analyzed nationally available data from OPTN and 
the CDC to demonstrate that while the percentage of donors from overdose rose 
nationally from 1.1% to 12.7% between 2000 and 2016, only 1.62% of all overdose 
deaths ended in organ donation13. This was despite 28.2% of overdose deaths occurring 
within healthcare facilities13 where it would appear that resuscitation, family discussions, 
and organ donation work up could be completed. So it would appear that there is much 
more potential for organ recovery from these cases moving forward.  This study also 




overdose donors. The region with the highest percentage of overdose deaths that led to 
donation was region 8 in the Midwestern US at 2.36% of overdose deaths which was 
more than double the rate in region 4 covering Texas and Oklahoma (Figure 4)13. This 
was despite the fact that region 8 had among the lowest overdose mortality rates (Figure 
5)13, which would indicate that they had more effective resources and strategies to lead to 
donation from overdoses as well as more aggressive local transplant centers who pursued 

















































To complete this project, the PubMed database and Google Scholar were utilized to track 
down relevant studies completed on the transplantation of organs from overdose donors 
completed over the last decade. This was done in order to get a sense of how the 
changing landscape of donation over that time was effected by the continued overdose 
epidemic. While going through these articles, it became clear that a major asset for this 
project would be the databases supplied by the Centers for Disease Control (The CDC), 




for Transplant Recipients (SRTR). These three databases had up to date information on 
the rates of overdose deaths, the rates of organ recovery from overdose death donors, and 
the various rates of transplant from overdose death donors and HCV positive donors. 
Additionally, the SRTR tracked and reported the openness of recipients on the transplant 







The issues surrounding the overdose epidemic and organ donation are wrought with 
ethical dilemmas and concerns. In any instance where the possibility for deceased donor 
organ donation exists, there is undoubtedly always an underlying tragedy. In many cases, 
these tragedies can lead to some good for others and additional peace for the family and 
loved ones of overdose victims if they are able to donate their organs to a person in need. 
Unfortunately, for many on the transplant waitlist, it would appear that there is still some 
missed opportunity for the maximizing of donated organs from the population of 
overdose deaths. As discussed above, in 2018 upwards of 28.3% of overdose deaths 
occurred in healthcare settings, while only 1.62% actually went forward with organ 
donation13. Understandably, the rest of the nearly 75% of overdose deaths that occur 
outside of healthcare settings would be difficult to move forward with due to having no 
infrastructure in the field for organ recovery. Some ideas have been put forth towards 
addressing this issue, which included a short run pilot program in New York City referred 
to as the Rapid Organ Recovery Ambulance Service14. This is a special ambulance 
service that would be sent out to maximize the potential for organ recovery from deaths 
that occur in the field and allow for more time to receive consent from family members to 
move forward with donation. This would be done by hooking up the recently deceased to 
a reperfusion machine in order to ensure that their organs are beings perfused after they 
are declared dead. This program was abandoned due to ethical concerns regarding the use 
of these measures on someone who is declared dead, and if reperfusion of deceased 




brain dead in the field with current standards and technology. This would constitute 
violate the “dead donor rule” which is the basis for deceased organ donation. It states that 
life critical organs can only be removed for donation after a donor is declared dead via 
circulatory cessation or a brain death diagnosis14. It also would require emergency 
responders to fulfill two rolls as both the resuscitator if there is a chance at saving a 
person’s life, or as the first line of the organ recovery process. This could create a 
question for the family about if all potential avenues for saving their loved one’s life were 
taken, which is already a misconception that the organ donation process is trying to 
combat regularly.  
 
So if the nearly 75% of overdose deaths outside of a healthcare setting are likely out of 
the realm of recovery, the main area of maximizing the potential for donated organs lies 
in maximizing those overdose fatalities that occur within a hospital or clinic. This could 
be achieved through a variety of ways including further education for staff to recognize 
when to refer a potential donor to their local OPO for the first stages of work up, or by 
having an automated referral system to cut down on the required time to make a referral.  
This would lessen the burden on the hospital staff making the referral, and increase the 
time available to the OPO to effectively mobilize and utilize their resources in order to 
maximize the potential for organ donation from overdoses. Additionally, increasing the 
use of reperfusion machines for organs in marginal donation settings such as donation 
after cardiac death (DCD) or donors with acute organ injury related to their anoxic event. 
Reperfusion machines already commonly used with kidney recovery in order to assess 




the technology reaches a sufficient point, it could open the door for increased recovery of 
organs from DCD donors or even open the door for recovery from field overdose deaths 
that the Rapid Organ Recovery Ambulance Service was designed to address.  
 
Further advances could be made by changing the national organ donor registry from an 
opt-in to an opt-out system. This would change the playing field by making it on the 
individual citizen to state that they do not wish to be an organ donor rather than making 
them state that they want to be an organ donor15. On the surface, this would immediately 
grow the pool of registered organ donors nationally and make some dent in the organ 
shortage that the country faces, but it would not address the shortage entirely or even 
make a huge impact. A 2019 study sought to estimate the effects that a change to an opt-
out system would have in the United States and found that it did note an improvement in 
the number of organs transplanted, particularly for livers and kidneys15. The study 
concluded that for livers with an ideal allocation to the recipients who could maximize 
the number of years’ post-transplant that an opt-out system added 2,109-2,125 total life 
years gained with a 5% increase in donation up to a 10,541 life years gained with 25% 
increased donation nationally15.  However, there are a host of ethical questions regarding 
the shift to an opt-out system rather than remaining with our current opt-in system.  And 
further, the infrastructure needed to maximize these available donors would need to be 
built out nationally. In fact, Spain, who instituted an opt-out donor registry in 1979 has 
stated that they found a greater effect on their donation numbers following the placement 
of dedicated donation coordinators within each hospital within the country16. So perhaps, 




OPOs and within hospitals in order to maximize the current pool of donors that we have 
access to rather than creating an opt-out donor system that has potential ethical concerns 





RECOMMENDATIONS FOR FUTURE STUDIES 
 
As discussed above, further study in the use of reperfusion machines for maintaining and 
assessing organ viability after recovery could go a long way towards maximizing 
donation from overdose donors. Additionally, further investigation into the ethical 
concerns around and the feasibility of programs such as the Rapid Organ Recovery 
Ambulance could open doors for recovery of organs from those who died in the field, as 
is often the case with overdoses.  
 
As far as evaluating the current missed opportunity, a further systematic review of all 
overdose deaths could be in order. By breaking them down by age, if they are declared 
dead upon arrival to the hospital, if they are resuscitated, if they are ventilated, and if they 
have a neurological work up prior to death could help to parse out how many of the 
overdose deaths that occur in healthcare settings actually do have viability for organ 
recovery given our current organ recovery system and technology. In addition to the 
above breakdowns, seeing if there are certain hospitals where additional resources could 
be spent to educate on the potential for donation from these overdose deaths could lead to 
more effective work between that hospital and their OPO.   
 
Lastly, further studies could be made into recipient mindset as they go through the organ 
transplant process. Following up on why they are concerned about accepting increased 




recipients willing to accept donated organs from overdose deaths. Furthermore, it could 
help transplant centers become more aggressive with accepting these donated organs and 
even pursue organs from HCV positive donors for their recipients regardless of their 
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